The AHA in comments today to the Centers for Medicare & Medicaid Services on its interim final rule for its COVID-19 vaccine mandate for hospitals and other participants in the Medicare and Medicaid program urged the agency to be flexible as it begins enforcement. Such flexibility and discretion in CMS’ enforcement, AHA said, will help mitigate uncertainty as court challenges to the mandate persist, while enabling hospitals and health systems to navigate workforce challenges without disrupting patient care. AHA also asked CMS to provide clarification for the agency’s complex, broad-sweeping interpretive guidance, including developing a means for hospitals to quickly get answers to their questions on compliance with the interim final rule.

Related News Articles

Headline
AHA today participated in a Centers for Disease Control and Prevention Fall Immunization Kick-off Event for partner organizations, which focused on vaccinating…
Headline
As authorized yesterday by the Food and Drug Administration and recommended by its vaccine advisory committee, the Centers for Disease Control and Prevention…
Headline
Under the Department of Health and Human Services’ recent agreement with Regeneron to develop a new monoclonal antibody to prevent COVID-19, the U.S. list…
Headline
In time for back-to-school health screenings, AHA Aug. 25 released an infographic on strategies that clinicians and the Centers for Disease Control and…
Headline
Receiving a COVID-19 mRNA vaccine or booster during pregnancy can benefit pregnant people and their newborn infants, according to findings from a federally…
Chairperson's File
It’s been about 65 years since an effective vaccine was first used worldwide against poliomyelitis, or polio. Until then, polio was responsible for about 500,…